BiotechTube
Home/ETS/AJ Ford
AF

AJ Ford

Chief Executive Officer (CEO)

ETS

Therapeutic Areas

Wound CareDiabetic Foot UlcersChronic WoundsSurgical Wounds

ETS Pipeline

DrugIndicationPhase
Mirragen for Diabetic Foot UlcersDiabetic Foot Ulcers (DFUs)Commercial
Mirragen for Other Chronic WoundsVenous Leg Ulcers, Pressure InjuriesResearch/Expansion
Mirragen Genomic ResearchChronic Wound Healing BiomarkersResearch

Leadership Team at ETS

DS
Dr. Steven Jung
Chief Technology Officer (CTO)
View full ETS profile